Table 3.
Male |
Female |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Variant | Chr | Position (bp) | A1 | Nearby gene | N | β/OR | SE | P | N | β/OR | SE | P |
rs12126655 | 1 | 108 158 343 | G | VAV3 | 1535 | 0.108 | 0.036 | 2.7 × 10−3 | 1964 | 0.157 | 0.034 | 2.7 × 10−6 |
rs2071403 | 2 | 1 396 251 | A | TPO | 1881 | 0.749 | 0.135 | 3.2 × 10−2 | 2337 | 0.551 | 0.095 | 4.1 × 10−10 |
Joint male and female | ||||||||||||
N | β/OR | SE | P | I2 | Het P | |||||||
rs12126655 | 3499 | 0.134 | 0.025 | 6.1 × 10−8 | 0 | 0.322 | ||||||
rs2071403 | 4218 | 0.610 | 0.078 | 2.3 × 10−10 | 71 | 0.063 |
Associations were tested with minor alleles by linear regression for TSH concentration and by logistic regression for anti-TPO antibody positivity. For TSH concentration, the effect size is shown as β and for anti-TPO antibody positivity as odds ratio (OR). The minor allele and its physical position are indexed to the positive strand of the NCBI build 36. The nearby gene is defined as the gene nearest to the variant within the boundary of the 50-kb distance. Chr, chromosome number; A1, minor allele; N, number of subjects; MAF, minor allele frequency; β, effect size of linear regression; SE, standard error; I2, heterogeneity estimate; Het P, P-value for heterogeneity.